Shire to Close U.S. Plasma Plant

Nov 04, 2016

BioPharma-Reporter

Shire says it is closing in December a plasma fractionating facility in Los Angeles, California, but remains positive it can successfully manage its post-Baxalta manufacturing network of 17 sites, according to an article in BioPharma-Reporter.

Shire's CEO Flemming Ornskov made the announcement during a conference call revealing its Q3 results and said the move was the first part of a "network strategy [which] will be laid out next year."

Read the full story

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments